• Trade Alert: Advisor to CEO & Director Of Incyte Herve Hoppenot Has Sold Stock simplywall.st Mon, 17 Nov 2025 12:54:23 GMT
• Incyte (INCY) Receives Positive Opinion for Minjuvi in Europe GuruFocus Mon, 17 Nov 2025 11:30:55 GMT
• Incyte's Minjuvi Gets EU Committee Recommendation as Potential Treatment for Follicular Lymphoma MarketScreener Mon, 17 Nov 2025 09:51:04 GMT
• CHMP recommends Incyte's Minjuvi for relapsed follicular lymphoma StreetInsider Mon, 17 Nov 2025 09:00:08 GMT
• (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma (FL) Business Wire Mon, 17 Nov 2025 06:00:00 GMT
• incyte announces positive chmp opinion for minjuvi® (tafasitamab) for the treatment of relapsed or refractory follicular lymphoma ... Yahoo Finance Mon, 17 Nov 2025 06:00:00 GMT
• Incyte (INCY) Valuation: Assessing Shares After Strong Earnings, Oncology Pipeline Progress, and Investor Optimism simplywall.st Sat, 15 Nov 2025 21:32:47 GMT
• STATE STREET CORP Reduces Stake in Incyte Corp: A Strategic Portfolio Adjustment GuruFocus Sat, 15 Nov 2025 00:51:05 GMT
• incyte corp. stock underperforms thursday when compared to competitors 富途牛牛 Fri, 14 Nov 2025 17:15:21 GMT
• Incyte Stock Outlook: Is Wall Street Bullish or Bearish? Yahoo Finance Fri, 14 Nov 2025 12:30:04 GMT
• Why Analysts See Incyte’s Story Shifting as Pipeline Progress Drives New Valuation Targets Yahoo Finance Fri, 14 Nov 2025 04:32:00 GMT
• incyte stock slumps after firm scraps drug, pauses enrollment in other study MSN Fri, 14 Nov 2025 04:26:59 GMT
• can incyte corporation (icy) stock attract analyst upgrades - insider selling & weekly high return stock opportunities newser.com Fri, 14 Nov 2025 02:53:38 GMT
• Incyte Corporation (INCY) Stock Price | Live Quotes & Charts | NASDAQ StocksToTrade Fri, 14 Nov 2025 02:34:05 GMT
• will incyte corporation (icy) stock enhance shareholder value - weekly investment summary & fast exit and entry strategy plans newser.com Thu, 13 Nov 2025 19:16:00 GMT
• incyte prepares to showcase pipeline momentum with new mutcalr data at ash 2025 MyChesCo Thu, 13 Nov 2025 19:00:00 GMT
• Incyte (INCY): Exploring Valuation After Recent Share Price Rally and Pipeline Progress Yahoo Finance Thu, 13 Nov 2025 14:15:44 GMT
• Why Incyte Corporation (ICY) stock stays resilient - July 2025 Big Picture & Real-Time Volume Analysis Alerts newser.com Thu, 13 Nov 2025 03:07:13 GMT
• incyte(incy.us) director sells us$19.77 million in common stock 富途牛牛 Thu, 13 Nov 2025 02:50:28 GMT
• prelude therapeutics reshapes pipeline with incyte deal and strategic refocus MSN Wed, 12 Nov 2025 20:19:04 GMT
• incyte stock hits 52-week high at 108.81 usd by investing.com Investing.com UK Wed, 12 Nov 2025 17:52:00 GMT
• prelude strikes $910 million deal with incyte for groundbreaking jak2 cancer therapy MSN Wed, 12 Nov 2025 16:01:29 GMT
• analysts conflicted on these healthcare names: incyte (incy), wave life sciences (wve) and bridgebio pharma (bbio) The Globe and Mail Wed, 12 Nov 2025 13:27:57 GMT
• incyte corp. stock underperforms tuesday when compared to competitors despite daily gains 富途牛牛 Tue, 11 Nov 2025 22:06:00 GMT
• Prelude Therapeutics Reshapes Pipeline With Incyte Deal and Strategic Refocus MyChesCo Tue, 11 Nov 2025 22:00:00 GMT
• The Bull Case For Incyte (INCY) Could Change Following Raised 2025 Guidance and Oncology Program Updates – Learn Why simplywall.st Tue, 11 Nov 2025 20:41:29 GMT
• Prelude Strikes $910 Million Deal With Incyte for Groundbreaking JAK2 Cancer Therapy MyChesCo Tue, 11 Nov 2025 20:00:00 GMT
• Incyte (NASDAQ:INCY) Q3 Earnings: Leading The Immuno-Oncology Pack Yahoo Finance Tue, 11 Nov 2025 03:31:00 GMT
• incyte and enable injections join forces to advance at-home cancer treatments MSN Mon, 10 Nov 2025 19:04:33 GMT
• Incyte at Guggenheim Conference: Strategic Focus on Innovation Investing.com Mon, 10 Nov 2025 16:46:01 GMT
• transcript : incyte corporation presents at guggenheim securities 2nd annual healthcare innovation conference, nov-10-2025 10 MarketScreener Mon, 10 Nov 2025 16:05:17 GMT
• key metrics from incyte corporation’s quarterly data - july 2025 decliners & daily stock trend reports newser.com Mon, 10 Nov 2025 11:46:50 GMT
• incyte posts 20% revenue growth, raises 2025 outlook on strong drug demand MyChesCo Mon, 10 Nov 2025 06:00:00 GMT
• is incyte corporation building a consolidation base - trend reversal & high conviction trade alerts newser.com Mon, 10 Nov 2025 02:20:50 GMT
• what risks investors should watch in incyte corporation stock - price action & free technical confirmation trade alerts newser.com Sun, 09 Nov 2025 21:28:36 GMT
• incyte and enable injections join forces to advance at-home cancer treatments MyChesCo Sun, 09 Nov 2025 20:00:00 GMT
• incyte to highlight innovation at major global healthcare conferences in november MyChesCo Sun, 09 Nov 2025 11:00:00 GMT
• A Fresh Look at Incyte (INCY) Valuation Following Upbeat Analyst Upgrades and 2025 Guidance Boost simplywall.st Sat, 08 Nov 2025 18:30:41 GMT
• prelude therapeutics (prld): evaluating valuation after incyte deal and strategic pipeline shift Sahm Sat, 08 Nov 2025 06:45:00 GMT
• prelude therapeutics (prld): valuation snapshot following incyte deal and pipeline realignment Yahoo Finance Sat, 08 Nov 2025 05:18:00 GMT
• incyte insider sold shares worth $534,813, according to a recent sec filing MarketScreener Fri, 07 Nov 2025 21:12:22 GMT
• urogen's exit makes agenus look smart | apexonco - clinical trials news and analysis Oncology Pipeline Fri, 07 Nov 2025 13:03:33 GMT
• how incyte corporation stock responds to policy changes - weekly trend report & smart money movement alerts newser.com Fri, 07 Nov 2025 10:55:19 GMT
• Prelude Therapeutics (PRLD): Valuation Snapshot Following Incyte Deal and Pipeline Realignment Yahoo Finance Fri, 07 Nov 2025 08:00:00 GMT
• incyte’s moments of clarity program expands to highlight powerful patient stories in vitiligo and pediatric eczema BioSpace Fri, 07 Nov 2025 05:58:07 GMT
• using python tools to backtest incyte corporation strategies - july 2025 preearnings & reliable intraday trade alerts newser.com Thu, 06 Nov 2025 10:59:49 GMT
• Is It Time to Reevaluate Incyte After Strong Pipeline Update and 52% Price Surge? Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• Incyte expands awards program to hidradenitis suppurativa ahead of FDA filing Fierce Pharma Thu, 06 Nov 2025 08:00:00 GMT
• Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema Yahoo Finance Thu, 06 Nov 2025 08:00:00 GMT
• will incyte corporation stock see pe expansion - 2025 technical overview & daily momentum trading reports fcp.pa.gov.br Thu, 06 Nov 2025 06:23:32 GMT
• how incyte corporation stock responds to policy changes - july 2025 gainers & consistent income trade ideas newser.com Thu, 06 Nov 2025 05:15:57 GMT
• can incyte corporation stock hit record highs again - 2025 analyst calls & low risk high reward ideas newser.com Thu, 06 Nov 2025 05:12:14 GMT
• real time alert setup for incyte corporation performance - weekly profit report & weekly breakout opportunity watchlist newser.com Wed, 05 Nov 2025 23:04:10 GMT
• multi asset correlation models including incyte corporation - quarterly profit report & risk managed investment entry signals newser.com Wed, 05 Nov 2025 22:57:04 GMT
• how incyte corporation stock responds to policy changes - july 2025 institutional & high accuracy buy signal tips newser.com Wed, 05 Nov 2025 22:43:36 GMT
• incyte (nasdaq:incy) stock price expected to rise, piper sandler analyst says MarketBeat Wed, 05 Nov 2025 16:58:13 GMT
• bofa securities maintains incyte(incy.us) with buy rating, raises target price to $114 富途牛牛 Wed, 05 Nov 2025 16:12:16 GMT
• incyte inks option agreement with prelude for jh2 inhibitor program MSN Wed, 05 Nov 2025 09:54:58 GMT
• key metrics from incyte corporation’s quarterly data - july 2025 intraday action & community consensus trade alerts newser.com Wed, 05 Nov 2025 09:50:14 GMT
• can incyte corporation stock hit record highs again - earnings trend report & stepwise trade execution plans newser.com Wed, 05 Nov 2025 08:52:40 GMT
• Incyte gets a Prelude insurance policy | ApexOnco - Clinical Trials news and analysis Oncology Pipeline Wed, 05 Nov 2025 08:00:00 GMT
• Prelude Therapeutics (PRLD) Is Up 14.3% After Incyte Option Deal and Pipeline Shift Has the Bull Case Changed? Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
• incyte (incy): buy, sell, or hold post q3 earnings? The Globe and Mail Wed, 05 Nov 2025 08:00:00 GMT
• incyte unveils game-changing mcalr trials – what it means for blood cancer treatment! Smartkarma Wed, 05 Nov 2025 06:04:14 GMT
• why prelude therapeutics (prld) is up 14.3% after incyte backs $25m private placement - and what's next Sahm Wed, 05 Nov 2025 05:03:45 GMT
• will incyte corporation (icy) stock return to pre crash levels - weekly profit analysis & reliable volume spike trade alerts newser.com Wed, 05 Nov 2025 03:28:16 GMT
• incyte (incy) secures exclusive option on jak2v617f program GuruFocus Wed, 05 Nov 2025 01:30:00 GMT
• is incyte corporation (icy) stock dividend growth reliable - july 2025 pullbacks & long-term growth plans newser.com Wed, 05 Nov 2025 00:25:05 GMT
• incyte price target raised to $102 from $82 at piper sandler TipRanks Tue, 04 Nov 2025 21:25:34 GMT
• incyte (incy) receives raised price target from piper sandler | GuruFocus Tue, 04 Nov 2025 17:19:23 GMT
• incyte (nasdaq:incy) hits new 52-week high after analyst upgrade MarketBeat Tue, 04 Nov 2025 15:18:18 GMT
• incyte (incy) secures $935m deal with prelude therapeutics for j GuruFocus Tue, 04 Nov 2025 15:05:53 GMT
• incyte aboard, smarca2 shift by prelude enshrouds foghorn BioWorld MedTech Tue, 04 Nov 2025 15:00:00 GMT
• incyte (nasdaq:incy) upgraded by guggenheim to buy rating MarketBeat Tue, 04 Nov 2025 13:17:17 GMT
• piper sandler adjusts incyte price target to $102 from $82, maintains overweight rating MarketScreener Tue, 04 Nov 2025 13:11:14 GMT
• incyte (incy) secures option for jak2v617f program in $910m deal GuruFocus Tue, 04 Nov 2025 13:07:30 GMT
• incyte secures option to acquire prelude’s jak2v617f inhibitor program Investing.com Tue, 04 Nov 2025 13:07:28 GMT
• incyte (incy) secures exclusive option on jak2v617f program GuruFocus Tue, 04 Nov 2025 13:07:11 GMT
• a quick look at today's ratings for incyte(incy.us), with a forecast between $75 to $125 富途牛牛 Tue, 04 Nov 2025 13:00:01 GMT
• prelude therapeutics stock climbs after exclusive jak2 option deal with incyte Investing.com Tue, 04 Nov 2025 12:30:15 GMT
• prelude therapeutics announces strategic updates: prioritizes jak2v617f and kat6a programs, pauses smarca2 development and secures... Quiver Quantitative Tue, 04 Nov 2025 12:15:00 GMT
• prelude (nasdaq: prld) signs incyte option for jak2v617f; $60m and pipeline refocus Stock Titan Tue, 04 Nov 2025 12:05:00 GMT
• hussman strategic advisors inc. boosts stock position in incyte corporation $incy MarketBeat Tue, 04 Nov 2025 11:30:18 GMT
• machina capital s.a.s. has $787,000 holdings in incyte corporation $incy MarketBeat Tue, 04 Nov 2025 10:36:12 GMT
• can incyte corporation stock deliver sustainable roe - 2025 pullback review & reliable breakout forecasts newser.com Tue, 04 Nov 2025 10:22:56 GMT
• incyte q3 2025 earnings: revenue & profit beat forecasts - news and statistics IndexBox Tue, 04 Nov 2025 08:25:00 GMT
• Prelude loses CMO, pauses SMARCA2 degraders and bags $60M from Incyte Fierce Biotech Tue, 04 Nov 2025 08:00:00 GMT
• Incyte (INCY) Extends Climb, Hits New High on Bullish Coverage Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• Incyte inks option agreement with Prelude for JH2 inhibitor program Seeking Alpha Tue, 04 Nov 2025 08:00:00 GMT
• Assessing Incyte’s Value After a 46.1% Stock Surge in 2025 simplywall.st Tue, 04 Nov 2025 08:00:00 GMT
• Incyte, Prelude ink rare blood cancer pact; Merck takes back rights to Prometheus asset Endpoints News Tue, 04 Nov 2025 08:00:00 GMT
• Incyte Enters Exclusive Option Agreement to Acquire Prelude Therapeutics' JAK2V617F Inhibitor Program for MPNs Quiver Quantitative Tue, 04 Nov 2025 08:00:00 GMT
• incyte's new ingenuity awards program focuses on empowering the hs community Dermatology Times Tue, 04 Nov 2025 08:00:00 GMT
• prelude therapeutics announces exclusive option agreement with incyte to advance mutant selective jak2v617f jh2 inhibitors Yahoo Finance Tue, 04 Nov 2025 08:00:00 GMT
• prelude (nasdaq: prld) grants incyte option on jak2v617f; $60m, $100m on exercise Stock Titan Tue, 04 Nov 2025 08:00:00 GMT
• the 5 most interesting analyst questions from incyte’s q3 earnings call Yahoo Finance Tue, 04 Nov 2025 05:38:00 GMT
• incyte announces more than 50 abstracts accepted for presentation at the 2025 ash annual meeting BioSpace Tue, 04 Nov 2025 02:25:37 GMT
• incyte corporation (incy) stock price | live quotes & charts | nasdaq StocksToTrade Tue, 04 Nov 2025 00:44:00 GMT
• is incyte corporation (icy) stock dividend growth reliable - july 2025 sector moves & community consensus trade alerts newser.com Tue, 04 Nov 2025 00:10:36 GMT
• incyte corporation (incy) stock price | live quotes & charts | nasdaq StocksToTrade Mon, 03 Nov 2025 23:27:00 GMT
• incyte (incy) upgraded to buy by guggenheim, price target set at $125 | incy stock news GuruFocus Mon, 03 Nov 2025 20:10:21 GMT
• incyte stock jumps on promising cancer data by investing.com Investing.com Australia Mon, 03 Nov 2025 19:50:15 GMT
• mizuho says incyte myelofibrosis efficacy data look ‘promising,’ but still early TipRanks Mon, 03 Nov 2025 18:42:56 GMT
• incyte (incy) shares rise following promising myelofibrosis data GuruFocus Mon, 03 Nov 2025 18:32:04 GMT
• incyte’s inca033989 shows promising initial results in myelofibrosis, but hold rating reflects need for further data TipRanks Mon, 03 Nov 2025 16:12:02 GMT
• incy: promising myelofibrosis treatment bolsters incyte's prospe GuruFocus Mon, 03 Nov 2025 15:31:41 GMT
• Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting Business Wire Mon, 03 Nov 2025 14:31:00 GMT
• leading vs lagging indicators on incyte corporation performance - bull run & weekly top gainers trade list newser.com Mon, 03 Nov 2025 13:38:16 GMT
• is incyte corporation building a consolidation base - portfolio value report & ai enhanced trading alerts newser.com Mon, 03 Nov 2025 13:36:45 GMT
• united states vitiligo forecast report 2025: a $320+ million market by 2033 featuring incyte, bms, clinuvel pharmaceuticals, astel... Business Wire Mon, 03 Nov 2025 13:29:00 GMT
• guggenheim upgrades incyte(incy.us) to buy rating, announces target price $125 富途牛牛 Mon, 03 Nov 2025 12:34:48 GMT
• warm autoimmune hemolytic anemia market size expected to grow openPR.com Mon, 03 Nov 2025 12:11:50 GMT
• incyte corporation $incy shares sold by south dakota investment council MarketBeat Mon, 03 Nov 2025 10:49:46 GMT
• does incyte corporation show high probability of rebound - market weekly review & verified swing trading watchlist newser.com Mon, 03 Nov 2025 09:50:36 GMT
• bessemer group inc. reduces stock holdings in incyte corporation $incy MarketBeat Mon, 03 Nov 2025 08:39:35 GMT
• how incyte corporation stock responds to policy changes - 2025 dividend review & risk controlled daily trade plans newser.com Mon, 03 Nov 2025 08:11:14 GMT
• The 5 Most Interesting Analyst Questions From Incyte’s Q3 Earnings Call Yahoo Finance Mon, 03 Nov 2025 08:00:00 GMT
• Incyte Corp. stock outperforms competitors on strong trading day MarketWatch Mon, 03 Nov 2025 08:00:00 GMT
• will incyte corporation (icy) stock see insider accumulation - weekly market outlook & momentum based trading ideas newser.com Mon, 03 Nov 2025 07:00:51 GMT
• strong q3 results and positive opzelura data could be a game changer for incyte (incy) simplywall.st Mon, 03 Nov 2025 01:28:30 GMT
• multi asset correlation models including incyte corporation - fed meeting & daily growth stock tips newser.com Mon, 03 Nov 2025 00:47:40 GMT
• incyte (nasdaq:incy) raised to "strong-buy" at wall street zen MarketBeat Sun, 02 Nov 2025 06:40:34 GMT
• exact sciences (exas) reports q3: everything you need to know ahead of earnings TradingView Sun, 02 Nov 2025 03:07:00 GMT
• will incyte corporation (icy) stock enhance shareholder value - weekly investment recap & technical pattern based signals newser.com Sun, 02 Nov 2025 01:52:27 GMT
• Incyte (INCY): Assessing Valuation After Strong Q3 Results and Upgraded Growth Outlook Sahm Sat, 01 Nov 2025 16:07:30 GMT
• real time alert setup for incyte corporation performance - 2025 risk factors & weekly setup with roi potential newser.com Sat, 01 Nov 2025 12:00:45 GMT
Incyte Corporation(NASDAQ:INCY) 
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera cancers; PEMAZYRE, a fibrobla...
Website: http://www.incyte.com
Founded: 2002
Full Time Employees: 1,456
Sector: Healthcare
Industry: Biotechnology